A carregar...
Anti-angiogenesis target therapy for advanced osteosarcoma
Osteosarcomas (OS), especially those with metastatic or unresectable disease, have limited treatment options. The greatest advancement in treatments occurred in the 1980s when multi-agent chemotherapy, including doxorubicin, cisplatin, high-dose methotrexate, and, in some regimens, ifosfamide, was d...
Na minha lista:
| Publicado no: | Oncol Rep |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5562076/ https://ncbi.nlm.nih.gov/pubmed/28656259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2017.5735 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|